针对关疾病的影响:一项随机临床试验
Lu Liu1, Qiuyi Chen1, Tianli Lyu1
1Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing 100010, China.
概括
与虚假针相比,针在患有关节障碍 (TMD) 的患者中显著降低了疼痛强度和改善功能. 这些好处在4周和8周观察到,表明TMD持续缓解疼痛.
科学领域:
- 综合医学是一个整体的医学.
- 疼痛管理 疼痛管理
- 肌肉骨系统疾病 肌肉骨系统疾病
背景情况:
- 部疾病 (TMD) 是面部疼痛和残疾的主要原因.
- 在全球范围内,TMD是肌肉骨疾病的第二大原因.
- 对TMD疼痛和功能限制的有效管理策略至关重要.
研究的目的:
- 评估针在缓解被诊断患有TMD的个体疼痛强度方面的疗效.
- 评估针对TMD患者各种功能和心理结果的影响.
主要方法:
- 一项随机对照试验,涉及60名患有TMD的参与者.
- 参与者每周接受针或假针治疗,持续4周.
- 主要结局:每周疼痛强度的变化;次要结局:功能改善,心理尺度和生理测量.
主要成果:
- 与假药组相比,针组在4周和8周显著减少疼痛强度.
- 在针组中,疼痛减轻率,下巴运动和功能尺度 (GCPS,JFLS-20) 显著改善.
- 在针治疗中观察到改善心理健康 (DASS-21) 和睡眠质量 (PSQI);在PPT或sEMG中没有差异.
结论:
- 针为患有TMD的患者提供了临床显著的疼痛减轻.
- 针对疼痛和功能的治疗效果延长至治疗后8周.
- 针改善了TMD患者的身体和情绪功能,超过了假冒干预.
相关概念视频
01:12What is an Experiment?
An experiment is a planned activity carried out under controlled conditions. The purpose of an experiment is to investigate the relationship between two variables. When one variable causes change in another, we call the first variable the explanatory or independent variable. The affected variable is called the response or dependent variable. In a randomized experiment, the researcher manipulates values of the explanatory variable and measures the resulting changes in the response variable. The...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...